US Patent 7723295 Peptides and compounds that bind to a receptor
Patent 7723295 was granted and assigned to Ortho-McNeil Pharmaceutical on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+152 characters)
Article
Patent abstract
Peptide compounds that bind to and activate the thrombopoietin receptor (c-mpl or TPO-R) or otherwise act as a TPO agonist are disclosed.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07723295 Peptides and compounds that bind to a receptor US Patent 7723295 Peptides and compounds that bind to a receptor
Infobox
Patent Number
0772329500
Patent Number
772329500
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077232950
Date of Patent
May 25, 2010
0Patent Application Number
112004160
Date Filed
August 9, 2005
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077232950
Date of Patent
May 25, 2010
0Patent Application Number
112004160
Date Filed
August 9, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07723295 Peptides and compounds that bind to a receptor
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07723295
Date of patent
May 25, 2010
Patent application number
11200416
Date Filed
August 9, 2005
Patent primary examiner
Find more entities like US Patent 7723295 Peptides and compounds that bind to a receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.